Therapeutic effect and complication profile of clonidine-beta-blocker combinations
Vanholder, R.; Lamiere, N.; Ringoir, S.
Kidney International. Supplement 25: S181-S183
1988
ISSN/ISBN: 0098-6577 PMID: 2903267 Document Number: 315179
Document emailed within 1 workday
Related Documents
Mohallen, K.L.; do Patrocínio, L.L.; Célnik, D.; Kruczan, D.D.; Pinheiro, L.; Weitzel, L.H.; Bosco, J.; Sekeff, J.A.; Azevedo, A.d.C. 1987: Normalization of ventricular compliance and hypertrophy in arterial hypertension. Double-blind study with 2 combinations of a beta blocker and diuretic Arquivos Brasileiros de Cardiologia 48(6): 345-350Furberg, C.D.; Byington, R.P. 1983: What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experience Circulation 67(6 Part 2): I98-101
Taylor, S.H. 1988: Pharmacological and therapeutic properties of an ideal beta-blocker Journal of International Medical Research 16(Suppl 1): 8a
Planz, G.; Planz, R.; Gierlichs, H.W.; Rahn, K.H. 1978: Effect of the beta-receptor blocker propranolol on the catecholamin level and dopamin-beta-hydroxylase in patients with essential hypertension Die Medizinische Welt 29(9): 366-367
Löllgen, H.; Schmidt, A.; Upmeyer, H.J. 1986: Double-blind comparison of fixed combination preparations of a beta blocker and a diuretic and beta blocker, a diuretic and hydralazine in patients with coronary heart disease and arterial hypertension Medizinische Klinik 81(23): 745-750
Andrianova, I.V.; Rekhter, M.D.; Tertov, V.V.; Andreeva, E.R.; Mironov, A.A.; Orekhov, A.N. 1992: Elimination of the atherogenic effect of beta blocker propranolol by papaverine Biulleten' Eksperimental'noi Biologii i Meditsiny 113(3): 273-275
Ivanova, O.V.; Fomicheva, O.A.; Sergakova, L.M.; Chernova, N.A.; Rogoza, A.N.; Karpov, Y.A. 2002: Angiotensin II receptor blocker telmisartan: effect on 24-hour blood pressure profile and left ventricular hypertrophy in patients with hypertension Kardiologiia 42(2): 45-49
Kozulitsyna, T.I.; Uvarova, O.A.; Golyshevskaia, V.I.; El'shanskaia, M.P. 1980: Experimental study of therapeutic effect of various antibacterial drug combinations Problemy Tuberkuleza 7: 49-53
Re, G.G.; Eandi, M.; Molinaris, F.; Taglia, P. 1980: Effect of a new beta-blocker (CM 6805) on the action potential of guinea pig atrial fiber Bollettino della Societa Italiana di Biologia Sperimentale 56(12): 1264-1270
Serradimigni, A.; Perchicot, E.; Griener, L.; Kerihuel, J.C.; Bénichou, M. 1985: Antihypertensive effect of a new form of nifedipine compared to a beta-blocker during chronic administration Archives des Maladies du Coeur et des Vaisseaux 78(Special Issue): 73-81
Petrikova, M.; Jancinova, V.; Nosal, R.; Majekova, M.; Fabryova, V. 2005: Carvedilol--a beta-blocker with considerable antiaggregatory effect on human blood platelets Bratislavske Lekarske Listy 106(1): 20-25
Bortolotto, L.A.; Ramires, J.A.; Serrano Junior, C.V.; Cesar, L.A.; Solimene, M.C.; da-Luz, P.L.; Pileggi, F. 1995: Beneficial effect of long-term use of a beta-blocker in patients before acute myocardial infarction Brazilian Journal of Medical and Biological Research 28(6): 637-642
Sievert, H.; Schmidt, T.; Frey, G.; Schräder, R.; van der Does, R.; Kaltenbach, M.; Kober, G. 1991: Neither propranolol nor the vasodilating beta-blocker carvedilol have a direct effect on coronary resistance vessels Zeitschrift für Kardiologie 80(1): 15-19
Biamino, G.; Schüren, K.P.; von Leitner, E. 1978: Effect of the beta blocker penbutolol on human hemodynamic parameters and the heart conduction system Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 697-700
Faragó, E.; Mihóczy, L. 1983: Monitoring of the plasma concentration of a beta blocker with retarded effect (Slow Trasicor, 160 mg) in humans International Journal of Clinical Pharmacology Therapy and Toxicology 21(7): 346-349
Balansard, P.; Chabrillat, Y.; Paulin, R.; Libes, M.; Gérard, R. 1977: Effect of atenolol, a new cardioselective beta-blocker, on plasma renin activity in treatment of hypertension Acta Cardiologica 32(4): 229-243
Kondo, M.; Nagano, H.; Sakon, M.; Hayashi, S.; Okami, J.; Dono, K.; Umeshita, K.; Nakamori, S.; Wakasa, K-ichi.; Monden, M. 2003: The effect of beta-blocker on intractable ascites in cirrhotic patients undergoing hepatectomy for hepatocellular carcinoma Hepato-Gastroenterology 50(50): 504-506
Kawanishi, D.T.; Reid, C.L.; Gonzales, A.; O'Rourke, R.A.; Rahimtoola, S.H. 1989: Response of blood pressure, cardiac output, peripheral resistance, and exercise performance to substitution of calcium blocker for beta-blocker plus thiazide diuretic therapy in patients with both systemic hypertension and mild stable angina Circulation 80(6 Suppl): Iv162-Iv170
Weth, G.; Schneider, J.; Rodatz, H.; Haubitz, I. 1985: The effect of the beta-blocker nadolol on the second messenger, serum cyclic adenosine monophosphate, and on blood pressure and heart rate Arzneimittel-Forschung 35(11): 1711-1713
Klieber, M.; Resch, F. 1986: Comparative studies of the effect of a cardioselective and a noncardioselective beta-blocker on peripheral circulation in patients with arterial occlusive disease Wiener Klinische Wochenschrift 98(3): 70-73